fashion -WSS

fashion

author：explore 2025-09-29 19:07:25 - browse：5111

George Yancopoulos on the 2024 Breakthrough Summit East stage. — George Yancopoulos on the 2024 Breakthrough Summit East stage STAT

George Yancopoulos is in touch with his teenage self.

After 35 years as head scientist at Regeneron Pharmaceuticals, Yancopoulos has led the development of 12 approved medicines, turning a once-fledgling company into the $100 billion global drugmaker it is today. And you can trace a straight line back to the childhood fascination with science he fostered growing up in Woodside, Queens.

“My high school science project was about regenerating neurons, and ‘Regeneron’ is a contraction of ‘regenerating neurons,’” Yancopoulos said at the STAT Summit East on Thursday. “In some ways I’m still working on my high school science project.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Prior authorization will have to move faster under new Biden rule

focus

WSS

Prior authorization will have to move faster under new Biden rule

Prior authorization will have to move faster under new Biden rule

A daunting task: navigating dual Medicare, Medicaid eligibility

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Surge of respiratory disease in China has likely explanation

Gain of function research would be limited under House proposal

knowledge

fashion

entertainment

Cancer drug shortages should be causing more outrage

The surgeon had a dilemma only a Nazi medical text could resolve

Duchenne breakthrough therapy leaves behind pioneering families

New brain studies show LSD's effects on the brain in full color

Supreme Court strikes down use of affirmative action

PBM reforms clear House panel

Novavax promises a turnaround & Lilly roils the obesity market

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Novavax promises a turnaround & Lilly roils the obesity market

FDA clears AI tool for detecting skin cancer

focus

NYU radiologists take on the challenge of expensive MRI machines

AI generated plenty of interest at JPM but not a lot of trust

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

The surgeon had a dilemma only a Nazi medical text could resolve

Why doctors need education on FDA device approval process

U.K. considers world's first use of meningitis vaccine to address gonorrhea

focus

knowledge

knowledge

Wikipedia